News Quantified

ARTL – artelo biosciences, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical

Artelo Biosciences (NASDAQ:ARTL) had its "hold" rating reaffirmed by analysts at Maxim Group.

Artelo Biosciences (NASDAQ:ARTL) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]

Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results

Form EFFECT ARTELO BIOSCIENCES, INC.

Form 8-K ARTELO BIOSCIENCES, INC. For: Nov 19

Form 3 ARTELO BIOSCIENCES, INC. For: Nov 01 Filed by: Spring Mark Edward

Form S-1 ARTELO BIOSCIENCES, INC.

Form 8-K ARTELO BIOSCIENCES, INC. For: Nov 10

Top News Gainers

6/21 Form EFFECT ARTELO BIOSCIENCES, INC. 284.3%

4/14 Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update 31.4%

2/3 Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program 23.3%

7/9 Artelo Biosciences (NASDAQ: ARTL) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. 20.1%

6/20 Form S-1/A ARTELO BIOSCIENCES, INC. 15.2%

11/1 Form 4 ARTELO BIOSCIENCES, INC. For: Oct 30 Filed by: Gorgas Gregory D. 9.2%

3/23 Artelo Biosciences to Present at the Spring Investor Summit on March 25th 8.8%

9/11 Artelo Biosciences to Present at the Fall Investor Summit in New York City on September 17th 7.3%

8/30 Form 4 ARTELO BIOSCIENCES, INC. For: Aug 29 Filed by: MATSUI CONNIE 7.2%

6/25 Form 8-K ARTELO BIOSCIENCES, INC. For: Jun 21 6.5%

Top News Decliners

10/17 Form 4 ARTELO BIOSCIENCES, INC. For: Oct 15 Filed by: Gorgas Gregory D. -21.0%

3/11 Form 8-K ARTELO BIOSCIENCES, INC. For: Mar 06 -15.9%

11/25 Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update -15.9%

6/10 Form S-1/A ARTELO BIOSCIENCES, INC. -15.4%

4/15 Form 8-K ARTELO BIOSCIENCES, INC. For: Apr 13 -14.0%

1/15 Form S-3 ARTELO BIOSCIENCES, INC. -13.6%

2/4 Form EFFECT ARTELO BIOSCIENCES, INC. -12.0%

2/14 Form SC 13G ARTELO BIOSCIENCES, INC. Filed by: Moss David J -10.6%

10/30 Form S-3 ARTELO BIOSCIENCES, INC. -9.1%

2/3 Artelo's [MarketWatch] -8.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day